# Therapeutic Response Evaluation and Adherence Trial (TREAT)

> **NCT02286154** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 150 (estimated)

## Conditions studied

- Anemia, Sickle Cell

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT02286154
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-10
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286154, "Therapeutic Response Evaluation and Adherence Trial (TREAT)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02286154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*